Solvias Receives Bronze Medal from EcoVadis
Solvias, a prominent global provider of Chemistry, Manufacturing, and Controls (CMC) analytics in the life sciences sector, has recently been awarded a Bronze Medal by EcoVadis, placing it in the top 35% of over 100,000 evaluated companies worldwide. This recognition underscores Solvias' commitment to sustainability and its significant progress in environmental, social, and governance (ESG) initiatives.
The Significance of the EcoVadis Bronze Medal
The EcoVadis assessment is a benchmark for sustainability performance, evaluating companies across four key categories: environment, labor and human rights, ethics, and sustainable procurement. By receiving the Bronze Medal, Solvias not only showcases its already established responsible business practices but also its ongoing efforts to enhance sustainability within its operations and value chain.
This milestone builds on a prior assessment in 2025 when Solvias received a Committed Badge, marking the start of its formal evaluation process for sustainability performance. This early recognition laid the groundwork for further advancements in the company’s environmental initiatives.
Strengthening ESG Integration in Global Operations
In 2024, Solvias launched a comprehensive ESG initiative aimed at fostering measurable improvements throughout its global operations and value chain. This strategic approach encompasses several important measures:
- - Calculating the company’s carbon footprint (Scope 1-3)
- - Setting sustainability objectives
- - Implementing a five-year ESG roadmap
- - Strengthening ethical business practices and sustainable procurement standards
Archie Cullen, CEO of Solvias, remarked, “Receiving the EcoVadis Bronze Medal reflects the substantial progress our teams have made in embedding sustainability into our operations and business practices. This acknowledgment highlights our commitment to continuous improvement while supporting our partners in responsibly advancing life-changing therapies.”
Promoting Sustainable Practices in the Life Science Sector
As a dedicated partner to pharmaceutical and biotech firms within the life sciences arena, Solvias remains committed to expanding initiatives designed to minimize environmental impact and enhance responsible business practices. The company’s long-term sustainability strategy aims to further align with internationally recognized frameworks, such as the Science Based Targets initiative (SBTi), alongside ongoing improvements in ESG transparency.
By placing sustainability at the core of its operational and strategic priorities, Solvias aims to support innovation in drug development while contributing to more sustainable supply chains in the healthcare and life sciences sectors.
About Solvias
Headquartered near Basel, Switzerland, Solvias stands as a global leader in analytical and regulatory services in the life sciences field, providing expert teams that support pharmaceutical and biotech companies in various domains, including small molecules, biological drugs, and novel modalities. Their analytical solutions span from raw material testing to drug release, ensuring compliance with the highest ISO, GMP, GLP, and FDA standards across five global Centers of Excellence.
For more information about Solvias and its initiatives, visit
www.solvias.com.